Epidemiological StudyPubMedMilitary Medicine
Prevalence of Obesity Medications in the Military Health System
Corrado RL, Meier M, Banaag A, et al.
Summary
Analysis of obesity medication prescribing patterns in the US Military Health System, showing growing adoption of GLP-1 receptor agonists.
Clinical Significance
Demonstrates the expanding real-world adoption of GLP-1 medications in institutional healthcare settings.
Key Findings
- Growing adoption of GLP-1 RAs in military healthcare
- Semaglutide and tirzepatide increasingly prescribed
- Reflects national trends in obesity pharmacotherapy
- Access and coverage considerations in military health system
Source
Cercetări conexe
In Vitro StudyPubMed
GLP-1 Analogs Activate AMP Kinase Leading to Reversal of the Warburg Effect in Breast Cancer Cells
GLP-1 receptor agonists were shown to activate AMP kinase and reverse the Warburg metabolic switch i…
GLP-1SemaglutideLiraglutide
Cardiovascular Outcomes TrialPubMed
Semaglutide and Cardiovascular Outcomes: SELECT Trial
In 17,604 patients with obesity and established cardiovascular disease (without diabetes), semagluti…
SemaglutideGLP-1
Model-Informed Drug Development (MIDD) / Post-hoc AnalysisPubMed
Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach
This Novo Nordisk study used model-informed drug development to evaluate whether semaglutide 1.7 mg …
Semaglutide
Systematic Review and Meta-AnalysisPubMed
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Depression: A Systematic Review and Meta-Analysis
This comprehensive meta-analysis evaluated the association between GLP-1 receptor agonist use and de…
GLP-1 receptor agonistssemaglutideliraglutide